Drug Shortage Report for M-M-R II
| Report ID | 221457 |
| Drug Identification Number | 00466085 |
| Brand name | M-M-R II |
| Common or Proper name | (measles, mumps and rubella virus vaccine, live, attenuated) Lyophilized powder for injection |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | RUBELLA VIRUS VACCINE LIVE ATTENUATED MUMPS VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED |
| Strength(s) | 1000UNIT 5000UNIT 1000UNIT |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 10 X 1 DOSE VIAL |
| ATC code | J07BD |
| ATC description | VIRAL VACCINES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2024-03-08 |
| Actual start date | 2024-03-06 |
| Estimated end date | 2024-05-17 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-04-04 |
| Company comments | Remaining doses are reserved for the public immunization program. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2024-04-04 | French | Compare |
| v7 | 2024-04-04 | English | Compare |
| v6 | 2024-03-07 | French | Compare |
| v5 | 2024-03-07 | English | Compare |
| v4 | 2024-03-07 | French | Compare |
| v3 | 2024-03-07 | English | Compare |
| v2 | 2024-03-06 | French | Compare |
| v1 | 2024-03-06 | English | Compare |
Showing 1 to 8 of 8